melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling
Melior Discovery

Our Services
High Throughput In Vivo Pharmacology:
Our Technology
 

in vivo models melior discovery theratrace

 

theraTRACE phenotypic screening melior discovery

 

Melior Pharmaceuticals drug development drug repostioning drug rescuing

 

              

 

             

 

                 

 

 

     Melior Discovery theraTRACE phenotypic screening in vivo pharmacology drug repositioning

Melior Discovery: opioid TRACE® Analgesic Profiling Platform

With the heightened interest in identifying low-abuse analgesics to address the opioid crisis, Melior has configured an in vivo platform aimed at specifically profiling opioid therapeutics and related analgesics. Specifically, this platform addresses the multiple features characteristic of opioids, including rodent models that evaluate:

• Acute analgesia
• Chronic analgesia
• Respiratory depression
GI mobility
Abuse liability

As with all of our multiplexed platforms, the specific composition and configuration of this platform is fully customizable depending upon your specific requirements.

Back to top of page

   



 

home theraTRACE Melior Pharmaceuticals